Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

NCT06574373 · clinicaltrials.gov ↗

RECRUITING

Status

3600

Enrollment

OTHER

Sponsor class

Conditions

IPMN, Pancreatic

Interventions

OTHER: Blood Collection Protocol for Patients with Indolent, Invasive, and Pancreatic Cancer-Associated IPMN Based on Clinical Course and Surgical Intervention

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborators

[object Object]
[object Object]
[object Object]